Cellular Biomedicine Group, Inc. (CBMG) financial statements (2020 and earlier)

Company profile

Business Address 1345 AVENUE OF THE AMERICAS
NEW YORK, NY 10105
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments155322391515
Cash and cash equivalents155322391515
Restricted cash and investments17     
Receivables 00010
Inventory, net of allowances, customer advances and progress billings    00
Inventory    00
Intangible current assets     11
Other current assets     0
Other undisclosed current assets22311(10)
Total current assets:345525411716
Noncurrent Assets
Operating lease, right-of-use asset20
Property, plant and equipment211513431
Long-term investments and receivables000157
Long-term investments000157
Intangible assets, net (including goodwill)8888819
Goodwill888888
Intangible assets, net (excluding goodwill)     11
Other undisclosed noncurrent assets14141616171
Total noncurrent assets:633737283328
TOTAL ASSETS:979261694944
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities421113
Accounts payable200000
Accrued liabilities221112
Taxes payable0000 1
Debt14     
Due to related parties     0
Other liabilities542121
Total current liabilities:2464234
Noncurrent Liabilities
Liabilities, other than long-term debt1800000
Accounts payable and accrued liabilities 00000
Other liabilities18     
Total noncurrent liabilities:1800000
Total liabilities:4264335
Stockholders' equity
Stockholders' equity attributable to parent568557664639
Common stock000000
Treasury stock, value(15)(14)(4)   
Additional paid in capital27225117315310475
Accumulated other comprehensive income (loss)(1)(1)(0)(1)(0)2
Accumulated deficit(200)(150)(111)(86)(57)(38)
Total stockholders' equity:568557664639
TOTAL LIABILITIES AND EQUITY:979261694944

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues002131
Revenue, net0131
Operating lease, lease income3
Other income112  
Cost of revenue(0)(0)(0)(1)(2)(0)
Cost of goods and services sold  (0)(1)(2)(0)
Other undisclosed gross profit  (2)(0)0 
Gross profit:000(0)10
Operating expenses(51)(41)(28)(29)(23)(13)
Other undisclosed operating income000120
Operating loss:(51)(41)(28)(28)(21)(12)
Nonoperating income122010
Other nonoperating income012010
Interest and debt expense(0)     
Loss from continuing operations before equity method investments, income taxes:(50)(39)(25)(28)(20)(12)
Other undisclosed income from continuing operations before income taxes0     
Loss from continuing operations before income taxes:(50)(39)(25)(28)(20)(12)
Income tax expense (benefit)(0)(0)(0)0(1)(0)
Loss from continuing operations:(50)(39)(25)(28)(21)(12)
Loss from discontinued operations     (3)
Net loss:(50)(39)(25)(28)(21)(16)
Other undisclosed net income (loss) attributable to parent   (0)10
Net loss available to common stockholders, diluted:(50)(39)(25)(28)(19)(15)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(50)(39)(25)(28)(21)(16)
Other comprehensive income (loss)0(1)1(1)(0)0
Comprehensive loss:(50)(40)(25)(29)(21)(16)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  (0)(0)02
Comprehensive loss, net of tax, attributable to parent:(50)(40)(25)(29)(21)(14)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: